This company has been acquired
Quantum Healthcare Past Earnings Performance
Past criteria checks 0/6
Key information
8.4%
Earnings growth rate
24.8%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | -39.9% |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 31 Dec 2021 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Quantum Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 21 | 0 | -4 | 2 | 0 |
30 Sep 21 | 0 | -1 | 3 | 0 |
30 Jun 21 | 0 | -4 | 3 | 1 |
31 Mar 21 | 0 | -6 | 3 | 3 |
31 Dec 20 | 1 | -8 | 3 | 4 |
30 Sep 20 | 1 | -10 | 4 | 5 |
30 Jun 20 | 4 | -9 | 4 | 6 |
31 Mar 20 | 6 | -9 | 4 | 5 |
31 Dec 19 | 8 | -10 | 4 | 6 |
30 Sep 19 | 10 | -10 | 4 | 6 |
30 Jun 19 | 9 | -16 | 6 | 7 |
31 Mar 19 | 10 | 2 | 7 | 8 |
31 Dec 18 | 11 | 30 | 8 | 7 |
30 Sep 18 | 12 | 28 | 9 | 7 |
30 Jun 18 | 14 | 31 | 10 | 6 |
31 Mar 18 | 14 | 11 | 11 | 6 |
31 Dec 17 | 14 | -23 | 12 | 5 |
30 Sep 17 | 13 | -29 | 15 | 6 |
30 Jun 17 | 11 | -35 | 16 | 8 |
31 Mar 17 | 10 | -14 | 18 | 8 |
31 Dec 16 | 11 | -12 | 18 | 9 |
30 Sep 16 | 12 | -9 | 20 | 9 |
30 Jun 16 | 12 | -33 | 22 | 8 |
31 Mar 16 | 13 | -54 | 22 | 8 |
31 Dec 15 | 12 | -53 | 23 | 8 |
30 Sep 15 | 13 | -53 | 21 | 9 |
Quality Earnings: QTVL.F is currently unprofitable.
Growing Profit Margin: QTVL.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: QTVL.F is unprofitable, but has reduced losses over the past 5 years at a rate of 8.4% per year.
Accelerating Growth: Unable to compare QTVL.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: QTVL.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.9%).
Return on Equity
High ROE: QTVL.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.